Keyphrases
American Cutaneous Leishmaniasis
100%
Reinfection
100%
Clinical Outcomes
100%
Hamster Model
100%
L. Panamensis
100%
L. Major
85%
Hamster
28%
Primary Infection
28%
Sham
14%
Promastigote
14%
Amastigote
14%
Intermediate Lesions
14%
Cross-protective
14%
New World Cutaneous Leishmaniasis
14%
Secondary Health Conditions
14%
Protective Response
14%
Primary Lesion
14%
Antimonials
14%
Active Lesions
14%
Subclinical Infection
14%
Secondary Lesions
14%
Leishmania Panamensis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Leishmaniasis
100%
Hamster Model
100%
Reinfection
100%
Infection
50%
Primary Infection
50%
Disease
25%
Amastigote
25%
Promastigote
25%
Asymptomatic Infection
25%
Antimonial
25%
Leishmania panamensis
25%
Immunology and Microbiology
Cutaneous Leishmaniasis
100%
Hamster Model
100%
Promastigote
50%
Amastigote
50%
Leishmania panamensis
50%
Biochemistry, Genetics and Molecular Biology
Hamster Model
100%
Single Drug Dose
50%
Promastigote
50%
Leishmania panamensis
50%
Amastigote
50%